Korean Drug Co. Ltd (014570) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.080x

Based on the latest financial reports, Korean Drug Co. Ltd (014570) has a cash flow conversion efficiency ratio of 0.080x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.60 Billion ≈ $4.47 Million USD) by net assets (₩82.31 Billion ≈ $55.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Korean Drug Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.

Korean Drug Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Korean Drug Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Korean Drug Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Korean Drug Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Korean Drug Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Coal Energy S.A. WAR:CLE	0.360x
FSBM Holdings Bhd KLSE:9377	-0.040x
Indo Acidatama Tbk JK:SRSN	0.060x
Aquarius Engines AM Ltd TA:AQUA	-32.231x
Lyka Labs Limited NSE:LYKALABS	0.135x
Actuate Therapeutics, Inc. Common stock NASDAQ:ACTU	-0.611x
A SPAC III Acquisition Corp. Class A Ordinary Shares NASDAQ:ASPC	-0.056x
FIGENE CAPITAL SA ZY 1 F:20X	N/A

Annual Cash Flow Conversion Efficiency for Korean Drug Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Korean Drug Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Korean Drug Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩83.07 Billion ≈ $56.30 Million	₩13.11 Billion ≈ $8.88 Million	0.158x	+153.18%
2024-12-31	₩78.11 Billion ≈ $52.93 Million	₩4.87 Billion ≈ $3.30 Million	0.062x	+340.45%
2023-12-31	₩77.09 Billion ≈ $52.24 Million	₩-2.00 Billion ≈ $-1.35 Million	-0.026x	-137.14%
2022-12-31	₩84.71 Billion ≈ $57.41 Million	₩5.91 Billion ≈ $4.01 Million	0.070x	-39.22%
2021-12-31	₩76.69 Billion ≈ $51.97 Million	₩8.81 Billion ≈ $5.97 Million	0.115x	-34.00%
2020-12-31	₩70.87 Billion ≈ $48.03 Million	₩12.33 Billion ≈ $8.36 Million	0.174x	+82.29%
2019-12-31	₩65.05 Billion ≈ $44.08 Million	₩6.21 Billion ≈ $4.21 Million	0.095x	+3.56%
2018-12-31	₩62.80 Billion ≈ $42.56 Million	₩5.79 Billion ≈ $3.92 Million	0.092x	+1074.16%
2017-12-31	₩56.97 Billion ≈ $38.61 Million	₩447.20 Million ≈ $303.06K	0.008x	-89.37%
2016-12-31	₩53.66 Billion ≈ $36.37 Million	₩3.96 Billion ≈ $2.69 Million	0.074x	-40.18%
2015-12-31	₩49.68 Billion ≈ $33.67 Million	₩6.13 Billion ≈ $4.16 Million	0.123x	+34.95%
2014-12-31	₩48.79 Billion ≈ $33.06 Million	₩4.46 Billion ≈ $3.02 Million	0.091x	--

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$24.65 Million

₩36.38 Billion KRW

Market Cap Rank

#24376 Global

#1713 in Korea

Share Price

₩3360.00

Change (1 day)

+0.00%

52-Week Range

₩3120.00 - ₩4710.00

All Time High

₩13030.58